查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000623

冠状动脉疾病诊断影像设备市场：按技术、应用和最终用户划分 - 2026-2032年全球市场预测

Coronary Heart Disease Diagnostic Imaging Devices Market by Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，冠状动脉疾病影像诊断设备市场价值将达到 28.4 亿美元，到 2026 年将成长至 31.3 亿美元，到 2032 年将达到 58.2 亿美元，复合年增长率为 10.79%。

主要市场统计数据
基准年 2025 28.4亿美元
预计年份：2026年 31.3亿美元
预测年份 2032 58.2亿美元
复合年增长率 (%) 10.79%

从综合观点探讨冠状动脉疾病的影像诊断，重点在于技术、临床工作流程和数据驱动决策的整合。

冠状动脉疾病的诊断越来越依赖一系列先进的影像技术，这些技术能够比单一技术更全面、更细緻地呈现临床影像。过去十年，影像技术已从单纯的解剖结构简介发展到整合结构、功能和分子资讯的综合评估，从而指导精准医疗。因此，临床医生、医院系统和供应商如今所处的环境，决定着设备间互通性、影像分析和工作流程整合的可行性，而这些因素既影响临床疗效，也影响商业性可行性。

人工智慧、混合成像、安全优化和基于价值的采购方面的进步如何从根本上改变诊断过程和供应商竞争。

冠状动脉疾病诊断影像领域正受到多种因素的共同影响，这些因素正在改变临床医生检测、量化和监测疾病的方式。人工智慧和先进的影像分析技术正从先导计画走向临床工作流程，实现斑块自动表征、灌注定量和分诊优先排序，从而缩短解读时间并提高结果的可重复性。同时，结合解剖和功能资讯的混合和多模态成像策略，例如CT衍生的血流储备分数和PET/CT联合通讯协定，正在提高诊断的准确性并减少对侵入性血管造影术的依赖。

本研究评估了基于关税的采购压力、供应链重组和成本转嫁趋势如何影响医疗设备的设计、分销和临床部署。

美国当年加征的关税对诊断影像技术的采购、製造策略和经济效益产生了连锁反应。进口零件关税导致成本上升，促使製造商重新评估其全球筹资策略，加快供应商多元化，并在许多情况下探索关键子组件的近岸外包或国内生产。这些供应链调整改变了前置作业时间、资本配置以及不同诊断影像平台之间的相对成本竞争力。

将设备架构、临床用例和医疗保健需求联繫起来的详细細項分析揭示了精确的采用因素和技术适用性。

一套精细的细分框架揭示了临床需求、技术能力和购买行为之间的交集，有助于明确产品策略和市场进入计划。按技术分类，该领域包括电脑断层扫描 (CT)、磁振造影(MRI)、光学成像、正子断层扫描 (PET)、单光子发射电脑断层扫描 (SPECT) 和超音波。特别是电脑断层扫描 (CT)，其架构可分为双源 CT、多切面CT 和单切片电脑断层扫描器等，每种架构都会在时间解析度、空间解析度和吞吐量之间做出不同的权衡。磁振造影(MRI) 则进一步细分为 1.5 特斯拉、3 特斯拉和 3 特斯拉以上磁场强度类别，这些类别会影响讯号杂讯比、扫描速度以及对高阶组织特性分析通讯协定的适用性。光学成像技术包括血管内成像方式，例如血管内光学同调断层扫描和近红外线光谱，这些技术透过评估斑块的微观结构和成分，对大血管成像起到补充作用。超音波系统在二维平台、3D容积成像和多普勒功能方面各不相同，可用于量化血流动力学。

区域医疗保健基础设施、报销制度和临床重点如何影响全球市场诊断影像技术的部署模式？

受医疗基础设施、法规环境和支付模式差异的影响，区域趋势塑造了创新轨迹和临床应用速度。在美洲，对三级医疗的大量资本投入以及对微创治疗路径的高度重视，推动了对先进电脑断层扫描（CT）、高场磁振造影（MRI）系统和混合成像解决方案的需求，这些方案能够减少不必要的侵入性诊断。从大学医院到社区医院和门诊诊所，人们对能够将诊断能力扩展到传统医院框架之外的携带式、经济高效的诊断设备也表现出浓厚的兴趣。

为什么企业正从以硬体为中心的销售模式转向整合软体、服务和临床证据的整合平台，以确保与医疗机构建立长期伙伴关係？

冠状动脉诊断影像领域的企业策略正趋向于一系列实际需求：平台模组化、透过服务和软体实现持续收入、临床证据的累积以及策略伙伴关係。领先的製造商不再局限于硬件，而是提供基于云端的分析、承包安装和维护合约以及临床医生培训项目，从而缩短产品实现临床价值所需的时间。这种转变反映出人们意识到，长期的客户关係和数据驱动的服务往往比一次性的设备销售更能带来更高的客户终身价值。

为了加快推广应用，我们为供应商和医疗保健系统制定了具体的策略重点，以平衡创新、价值链韧性和基于价值的商业模式。

产业领导企业应采取多管齐下的策略，重点关注临床结果、营运韧性和灵活的商业模式，以最大限度地提高产品普及率和长期价值。首先，他们应优先投资于人工智慧驱动的影像分析和工作流程自动化，以显着缩短解读时间和降低放射科医生之间的差异。先导计画的设计应旨在获取临床终点和经济效益数据，从而为报销谈判和采购核准奠定基础。其次，他们应重新设计产品系列，并专注于模组化。这将允许透过更换软体和模组化硬体来升级核心平台，而不是完全更换设备，从而在减少采购摩擦的同时，维护客户关係。

采用严谨的混合方法研究框架，结合临床医师访谈、技术文件审查、供应链映射和情境分析，以检验策略结论。

本分析整合了多种证据来源，以确保方法论的严谨性和实务有效性。主要调查包括对临床医生、采购经理和医疗设备工程师进行结构化访谈，以收集有关临床需求、采购限制和技术偏好的第一手资讯。除这些访谈外，专家咨询小组的检验也支持了诸如人工智慧整合、混合成像实施以及贸易政策变化对营运的影响等新兴主题。次要分析则利用同侪审查文献、监管文件、医疗设备技术规格和已发布的临床指南，全面检验了跨模态性能特征和临床效用。

结论强调需要将临床检验、模组化产品策略和服务主导的商业性方法结合起来，以创造长期价值。

总而言之，冠状动脉疾病诊断影像生态系统正处于转折点，透过技术成熟度、数据分析和不断演进的采购模式，重新定义临床路径。最成功的方案是将高清显像模式与人工智慧驱动的分析、模组化升级以及使供应商奖励与临床结果一致的服务模式相结合。贸易政策的波动和区域基础设施的差异既带来风险也带来机会，从而促进供应链韧性和区域性客製化策略的发展。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：冠状动脉疾病诊断影像设备市场：依技术划分

  • CT
    • 双源CT
    • 多切面CT
    • 单切片电脑断层扫描器
  • MRI
    • 1.5T
    • 3T
    • 3吨或以上
  • 光学成像
    • IVOCT
    • NIRS
  • PET
  • SPECT
  • 超音波
    • 2D
    • 3D
    • 多普勒

第九章：冠状动脉疾病诊断影像设备市场：依应用领域划分

  • 解剖学评估
  • 灌注影像
    • 静止状态下的灌注
    • 负荷下灌注
  • 生物医学影像

第十章：冠状动脉疾病诊断影像设备市场：依最终使用者划分

  • 门诊部
  • 诊断中心
  • 医院
  • 专科诊所

第十一章：冠状动脉疾病诊断影像设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章：冠状动脉疾病诊断影像设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章：冠状动脉疾病诊断影像设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国冠状动脉疾病诊断影像设备市场

第十五章：中国冠状动脉疾病诊断影像设备市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • AngioDynamics, Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technologies Co., Ltd.
  • Edwards Lifesciences Corporation
  • Epsilon Imaging, Inc.
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Heart Test Laboratories, Inc.
  • Hill-Rom Holdings, Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • LivaNova PLC
  • Merit Medical Systems, Inc.
  • Mindray Medical International Limited
  • Siemens AG
  • Terumo Medical Corporation
  • TOMTEC Imaging Systems GmbH
  • Toshiba Corporation
  • Translumina GmbH
Product Code: MRR-8C74ADFC03A3

The Coronary Heart Disease Diagnostic Imaging Devices Market was valued at USD 2.84 billion in 2025 and is projected to grow to USD 3.13 billion in 2026, with a CAGR of 10.79%, reaching USD 5.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.84 billion
Estimated Year [2026] USD 3.13 billion
Forecast Year [2032] USD 5.82 billion
CAGR (%) 10.79%

An integrative perspective on coronary heart disease diagnostic imaging that highlights the convergence of technology, clinical workflows, and data-driven decision making

The diagnosis of coronary heart disease increasingly relies on an array of advanced imaging modalities that together create a richer, more nuanced clinical picture than any single technique could provide alone. Over the last decade, imaging has shifted from standalone anatomical snapshots to integrated assessments that combine structural, functional, and molecular information to guide precision care. As a result, clinicians, hospital systems, and technology vendors now operate in an environment where device interoperability, image analytics, and workflow integration determine both clinical impact and commercial viability.

In clinical practice, the imperative is clear: deliver faster, more accurate diagnosis while minimizing patient risk and streamlining care pathways. Technological advances, regulatory rigor, and evolving reimbursement practices are converging to reward solutions that shorten time to diagnosis, reduce unnecessary invasive procedures, and enable longitudinal disease management. This introduction frames the remainder of the executive summary by emphasizing that successful market actors will be those who align engineering innovation with clinical utility, workflow optimization, and data-driven decision support.

Consequently, stakeholders must understand not only the capabilities of individual imaging platforms but also how they function within complex care ecosystems. From point-of-care ultrasound that improves bedside triage to high-resolution computed tomography that informs interventional planning, each modality contributes to a continuum of care. The subsequent sections synthesize transformative trends, trade policy impacts, segmentation nuances, regional variations, corporate strategies, and practical recommendations that together chart a pathway for leaders in coronary heart disease diagnostic imaging.

How advances in artificial intelligence, hybrid imaging, safety optimization, and value-based procurement are fundamentally reshaping diagnostic pathways and vendor competition

The landscape of coronary heart disease diagnostic imaging is being reshaped by several convergent forces that are transforming how clinicians detect, quantify, and monitor disease. Artificial intelligence and advanced image analytics have moved from pilot projects into clinical workflows, enabling automated plaque characterization, perfusion quantification, and triage prioritization that reduce interpretation time and enhance reproducibility. Simultaneously, hybrid and multimodal imaging strategies that pair anatomical and functional information-such as computed tomography-derived fractional flow reserve and combined PET/CT protocols-are increasing diagnostic confidence and reducing the reliance on invasive angiography.

Another pivotal shift is the relentless drive toward dose reduction and patient safety. Innovations in reconstruction algorithms, detector design, and contrast usage are allowing for high-fidelity images at markedly lower radiation and contrast loads, which broadens the suitability of advanced imaging for frail and comorbid populations. At the same time, the emergence of point-of-care and compact systems, particularly in ultrasound and lower-field MR, is decentralizing diagnostics and enabling faster decision-making in ambulatory and emergency settings.

Operationally, payers and health systems are accelerating adoption of value-based procurement models that prioritize outcomes, throughput, and total cost of care. This is prompting vendors to offer bundled service contracts, performance guarantees, and cloud-enabled subscription services. Finally, global supply chain optimization and localized manufacturing are becoming strategic imperatives as vendors seek resilience against geopolitical disruption and cost volatility. In combination, these shifts are expanding clinical capability while intensifying competition around integration, scalability, and demonstrable clinical value.

Assessing how tariff-driven procurement pressures, supply chain realignments, and cost pass-through dynamics are influencing device design, distribution, and clinical adoption

United States tariff measures implemented in the year in question have had a cascading impact on procurement, manufacturing strategies, and the economics of diagnostic imaging technologies. Tariff-induced cost increases for imported components prompted manufacturers to reassess global sourcing strategies, accelerate supplier diversification, and in many cases explore nearshoring or domestic production for critical subassemblies. These supply chain adaptations have altered lead times, capital allocation, and the relative cost competitiveness of different imaging platforms.

As procurement costs rose for certain imported devices and parts, healthcare providers and integrated delivery networks intensified scrutiny of total cost of ownership, favoring systems that promised long-term serviceability, remote diagnostics, and modular upgrade paths. In parallel, some vendors absorbed tariff-related expenses to protect their market positioning, while others passed incremental costs to purchasers, creating differential pricing pressure across hospitals, diagnostic centers, and ambulatory settings.

Tariffs also influenced innovation pathways. Budgetary constraints and procurement unpredictability pushed OEMs toward platform designs that reduced reliance on tariff-exposed components and emphasized software-driven differentiation. Regulatory interactions shifted as well, with companies prioritizing devices and modifications that offered quick, high-value clinical returns within constrained capital cycles. Finally, trade policy fostered strategic partnerships between manufacturers and regional distributors to mitigate customs complexity and to establish more predictable contractual arrangements. Taken together, these effects underscore that trade measures can accelerate structural change across the industry by catalyzing supply chain resilience, design modularity, and commercial flexibility.

Detailed segmentation analysis linking device architectures, clinical use cases, and care setting requirements to reveal precise adoption drivers and technology fit

A nuanced segmentation framework reveals where clinical demand intersects with technological capability and purchasing behavior, providing clarity for product strategy and go-to-market planning. When examined by technology, the field comprises computed tomography, magnetic resonance imaging, optical imaging modalities, positron emission tomography, single-photon emission computed tomography, and ultrasound. Computed tomography in particular is differentiated by architectures such as dual-source CT, multi-slice CT, and single-slice CT, each offering distinct trade-offs between temporal resolution, spatial resolution, and throughput. Magnetic resonance imaging is further stratified by field strength categories of one point five tesla, three tesla, and above three tesla, which influence signal-to-noise, acquisition speed, and suitability for advanced tissue characterization protocols. Optical imaging techniques include intracoronary modalities such as intravascular optical coherence tomography and near-infrared spectroscopy, which provide microstructural and compositional plaque assessment that complements macrovascular imaging. Ultrasound systems vary across two-dimensional platforms, three-dimensional volumetric imaging, and Doppler capabilities that quantify flow dynamics.

Looking through the lens of end users, adoption patterns diverge across ambulatory care centers, diagnostic centers, hospitals, and specialty clinics, with each setting prioritizing a different mix of capital intensity, throughput, and clinical flexibility. Diagnostic objectives cluster into anatomical assessment, perfusion imaging, and viability imaging, where perfusion protocols themselves bifurcate into resting perfusion and stress perfusion paradigms that drive different hardware and software requirements. Understanding these segments together illuminates the trade-offs clinicians and procurement teams weigh: speed versus precision, portability versus comprehensive capability, and capital expenditure versus per-scan economics. Consequently, vendors and health systems that map product features to specific clinical workflows and procurement constraints will achieve clearer differentiation and higher adoption velocity.

How regional healthcare infrastructure, reimbursement frameworks, and clinical priorities are driving divergent adoption models for diagnostic imaging across global markets

Regional dynamics are shaping both the trajectory of innovation and the pace of clinical uptake, driven by variations in healthcare infrastructure, regulatory environments, and payer models. In the Americas, high levels of capital investment in tertiary centers and a strong emphasis on minimally invasive care pathways are driving demand for advanced computed tomography, high-field magnetic resonance systems, and hybrid imaging solutions that reduce unnecessary invasive diagnostics. Transitioning from academic centers to community hospitals and ambulatory settings, there is also significant interest in portable, cost-effective modalities that can extend diagnostic capability outside traditional hospital walls.

Europe, Middle East & Africa exhibits considerable heterogeneity: established Western European healthcare systems are rapidly adopting dose-reduction technologies and AI-enabled analytics, while parts of the Middle East prioritize flagship tertiary investments and emerging clinical networks. In Africa, the imperative often centers on access and reliability, pushing adoption toward robust, low-maintenance systems and tele-radiology partnerships that can amplify limited specialist capacity. Reimbursement structures and cross-border regulatory harmonization in this region exert a strong influence on procurement cycles and vendor strategies.

Asia-Pacific continues to be a dynamic growth arena, propelled by large population bases, expanding middle-class demand for advanced diagnostics, and national investments in healthcare infrastructure. Regional manufacturers and international OEMs compete aggressively on service models, price-performance ratios, and local partnerships. Across all regions, interoperability, cloud-enabled image sharing, and training programs remain central to adoption, but the balance between high-end tertiary investments and decentralized diagnostic access varies significantly by geography, shaping distinct commercial approaches.

Why companies are shifting from hardware-centric sales to integrated platforms that combine software, services, and clinical evidence to secure long-term institutional partnerships

Corporate strategies within the coronary diagnostic imaging arena are converging around a set of practical imperatives: platform modularity, recurring revenue through service and software, clinical evidence generation, and strategic partnerships. Leading manufacturers are expanding beyond hardware to offer cloud-enabled analytics, turnkey installation and maintenance contracts, and clinician training programs that accelerate time to clinical value. This shift reflects an understanding that long-term customer relationships and data-driven services often yield higher lifetime value than one-time equipment sales.

Mergers, strategic alliances, and targeted acquisitions continue to be a primary route for companies seeking rapid entry into complementary technologies, such as AI startups focused on plaque detection or specialist firms developing coronary perfusion quantification software. Additionally, strategic investors are placing emphasis on companies that demonstrate clear clinical outcomes, regulatory clearance pathways, and scalable deployment models for varied care settings. Service differentiation increasingly includes remote monitoring of system health, predictive maintenance, and outcome-linked contracting that aligns vendor incentives with institutional goals.

Finally, competition for talent-engineers, clinical specialists, and regulatory experts-is shaping innovation pipelines. Organizations that combine clinical domain expertise with software and cloud engineering capabilities are better positioned to deliver integrated solutions that meet the needs of multi-disciplinary cardiac teams. As a result, product roadmaps now commonly reflect a combination of hardware improvements, modular software upgrades, and ecosystem partnerships aimed at delivering measurable improvements in diagnostic accuracy, workflow efficiency, and patient experience.

Actionable strategic priorities for vendors and health systems that balance innovation, supply chain resilience, and value-based commercial models to accelerate adoption

Industry leaders should adopt a multi-pronged strategy that emphasizes clinical outcomes, operational resilience, and flexible commercial models to maximize adoption and long-term value. First, prioritize investments in AI-driven image analysis and workflow automation that demonstrably reduce interpretation time and inter-reader variability; pilot projects should be designed to capture clinical endpoints and economic benefits to enable reimbursement discussions and procurement approvals. Second, redesign product portfolios to emphasize modularity, enabling core platforms to be upgraded via software or modular hardware swaps rather than full capital replacement, which preserves customer relationships and reduces procurement friction.

Third, strengthen supply chain resilience by diversifying suppliers, qualifying alternative component sources, and evaluating nearshoring options for critical manufacturing steps. These measures will reduce exposure to tariff volatility and logistical disruption while improving lead time predictability for customers. Fourth, expand service and subscription offerings that bundle analytics, uptime guarantees, and training, thereby creating recurring revenue streams and aligning vendor incentives with clinical and operational outcomes. Fifth, pursue targeted partnerships with health systems and payers to generate real-world evidence that supports value-based contracting and to create joint pilots that illustrate reduced invasive procedural rates or improved patient throughput.

Finally, tailor go-to-market approaches by region and care setting, recognizing the different procurement drivers across tertiary hospitals, diagnostic centers, ambulatory care sites, and specialty clinics. Investments in clinician education, tele-radiology networks, and local service capabilities will accelerate adoption in markets with constrained specialist availability, while bundled offerings and outcome guarantees will resonate in systems prioritizing total cost of care.

A rigorous mixed-methods research framework combining clinician interviews, technical dossier review, supply chain mapping, and scenario analysis to validate strategic conclusions

This analysis synthesizes multiple evidence streams to ensure methodological rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, and device engineers to capture frontline insights into clinical requirements, procurement constraints, and technology preferences. These conversations were complemented by expert advisory panels that validated emerging themes such as AI integration, hybrid imaging adoption, and the operational impact of trade policy changes. Secondary analysis drew upon peer-reviewed literature, regulatory filings, device technical specifications, and published clinical guidelines to triangulate performance characteristics and clinical utility across modalities.

To understand commercial and supply chain implications, the research incorporated qualitative supplier mapping, contract review summaries, and scenario analysis of tariff and logistics disruptions. Product roadmaps and patent trends were examined to identify areas of technological differentiation and potential competitive entry points. Finally, findings were stress-tested through scenario planning workshops that modeled adoption pathways across different reimbursement and investment environments, providing robust directional guidance for stakeholders seeking to align product strategy with clinical demand and procurement realities.

Concluding synthesis that underscores the imperative to align clinical validation, modular product strategy, and service-led commercial approaches to capture long-term value

In summary, the diagnostic imaging ecosystem for coronary heart disease is at an inflection point where technological maturity, data analytics, and changing procurement models are collectively redefining clinical pathways. The most successful approaches will integrate high-fidelity imaging modalities with AI-enabled analysis, modular upgradeability, and service models that align vendor incentives with clinical outcomes. Trade policy fluctuations and regional differences in infrastructure create both risk and opportunity, incentivizing supply chain resilience and tailored regional strategies.

Stakeholders-from device manufacturers to hospital executives-must therefore prioritize investments that reduce time to diagnosis, lower procedural risk, and demonstrably improve patient outcomes while maintaining operational flexibility. By focusing on modular platforms, evidence-generation partnerships, and recurrent service revenues, organizations can build defensible positions in a market increasingly driven by interoperability and value-based procurement. The overarching conclusion is clear: combining clinical validation with scalable commercial models will determine who leads the next wave of diagnostic innovation in coronary care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Heart Disease Diagnostic Imaging Devices Market, by Technology

  • 8.1. CT
    • 8.1.1. Dual-Source CT
    • 8.1.2. Multi-Slice CT
    • 8.1.3. Single-Slice CT
  • 8.2. MRI
    • 8.2.1. 1.5T
    • 8.2.2. 3T
    • 8.2.3. Above 3T
  • 8.3. Optical Imaging
    • 8.3.1. IVOCT
    • 8.3.2. NIRS
  • 8.4. PET
  • 8.5. SPECT
  • 8.6. Ultrasound
    • 8.6.1. 2D
    • 8.6.2. 3D
    • 8.6.3. Doppler

9. Coronary Heart Disease Diagnostic Imaging Devices Market, by Application

  • 9.1. Anatomical Assessment
  • 9.2. Perfusion Imaging
    • 9.2.1. Resting Perfusion
    • 9.2.2. Stress Perfusion
  • 9.3. Viability Imaging

10. Coronary Heart Disease Diagnostic Imaging Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Coronary Heart Disease Diagnostic Imaging Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Coronary Heart Disease Diagnostic Imaging Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Coronary Heart Disease Diagnostic Imaging Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Coronary Heart Disease Diagnostic Imaging Devices Market

15. China Coronary Heart Disease Diagnostic Imaging Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agfa-Gevaert Group
  • 16.6. Analogic Corporation
  • 16.7. AngioDynamics, Inc.
  • 16.8. Canon Medical Systems Corporation
  • 16.9. Chison Medical Technologies Co., Ltd.
  • 16.10. Edwards Lifesciences Corporation
  • 16.11. Epsilon Imaging, Inc.
  • 16.12. FUJIFILM Corporation
  • 16.13. GE HealthCare Technologies Inc.
  • 16.14. Heart Test Laboratories, Inc.
  • 16.15. Hill-Rom Holdings, Inc.
  • 16.16. Hitachi, Ltd.
  • 16.17. Koninklijke Philips N.V.
  • 16.18. LivaNova PLC
  • 16.19. Merit Medical Systems, Inc.
  • 16.20. Mindray Medical International Limited
  • 16.21. Siemens AG
  • 16.22. Terumo Medical Corporation
  • 16.23. TOMTEC Imaging Systems GmbH
  • 16.24. Toshiba Corporation
  • 16.25. Translumina GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 177. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 204. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 213. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)